596 related articles for article (PubMed ID: 24249111)
1. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation.
Turner JE; Morrison PJ; Wilhelm C; Wilson M; Ahlfors H; Renauld JC; Panzer U; Helmby H; Stockinger B
J Exp Med; 2013 Dec; 210(13):2951-65. PubMed ID: 24249111
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.
Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D
Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965
[TBL] [Abstract][Full Text] [Related]
3. Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung.
Bando JK; Nussbaum JC; Liang HE; Locksley RM
J Leukoc Biol; 2013 Nov; 94(5):877-84. PubMed ID: 23924659
[TBL] [Abstract][Full Text] [Related]
4. Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis.
Mohapatra A; Van Dyken SJ; Schneider C; Nussbaum JC; Liang HE; Locksley RM
Mucosal Immunol; 2016 Jan; 9(1):275-86. PubMed ID: 26129648
[TBL] [Abstract][Full Text] [Related]
5. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
6. Nematode-Infected Mice Acquire Resistance to Subsequent Infection With Unrelated Nematode by Inducing Highly Responsive Group 2 Innate Lymphoid Cells in the Lung.
Yasuda K; Adachi T; Koida A; Nakanishi K
Front Immunol; 2018; 9():2132. PubMed ID: 30283458
[TBL] [Abstract][Full Text] [Related]
7. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.
Flamar AL; Klose CSN; Moeller JB; Mahlakõiv T; Bessman NJ; Zhang W; Moriyama S; Stokic-Trtica V; Rankin LC; Putzel GG; Rodewald HR; He Z; Chen L; Lira SA; Karsenty G; Artis D
Immunity; 2020 Apr; 52(4):606-619.e6. PubMed ID: 32160524
[TBL] [Abstract][Full Text] [Related]
9. IL-4/IL-13-producing ILC2s are required for timely control of intestinal helminth infection in mice.
Varela F; Symowski C; Pollock J; Wirtz S; Voehringer D
Eur J Immunol; 2022 Dec; 52(12):1925-1933. PubMed ID: 36116042
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.
Nagashima H; Mahlakõiv T; Shih HY; Davis FP; Meylan F; Huang Y; Harrison OJ; Yao C; Mikami Y; Urban JF; Caron KM; Belkaid Y; Kanno Y; Artis D; O'Shea JJ
Immunity; 2019 Oct; 51(4):682-695.e6. PubMed ID: 31353223
[TBL] [Abstract][Full Text] [Related]
11. Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses.
Lok LSC; Walker JA; Jolin HE; Scanlon ST; Ishii M; Fallon PG; McKenzie ANJ; Clatworthy MR
Front Immunol; 2021; 12():711907. PubMed ID: 34484215
[TBL] [Abstract][Full Text] [Related]
12. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
13. Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition.
Inclan-Rico JM; Ponessa JJ; Valero-Pacheco N; Hernandez CM; Sy CB; Lemenze AD; Beaulieu AM; Siracusa MC
Nat Immunol; 2020 Oct; 21(10):1181-1193. PubMed ID: 32807943
[TBL] [Abstract][Full Text] [Related]
14. BATF acts as an essential regulator of IL-25-responsive migratory ILC2 cell fate and function.
Miller MM; Patel PS; Bao K; Danhorn T; O'Connor BP; Reinhardt RL
Sci Immunol; 2020 Jan; 5(43):. PubMed ID: 31924686
[TBL] [Abstract][Full Text] [Related]
15. IL-7 induces type 2 cytokine response in lung ILC2s and regulates GATA3 and CD25 expression.
Sheikh A; Lu J; Melese E; Seo JH; Abraham N
J Leukoc Biol; 2022 Nov; 112(5):1105-1113. PubMed ID: 35603486
[TBL] [Abstract][Full Text] [Related]
16. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1.
Spooner CJ; Lesch J; Yan D; Khan AA; Abbas A; Ramirez-Carrozzi V; Zhou M; Soriano R; Eastham-Anderson J; Diehl L; Lee WP; Modrusan Z; Pappu R; Xu M; DeVoss J; Singh H
Nat Immunol; 2013 Dec; 14(12):1229-36. PubMed ID: 24141388
[TBL] [Abstract][Full Text] [Related]
17. Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis.
Borthwick LA; Barron L; Hart KM; Vannella KM; Thompson RW; Oland S; Cheever A; Sciurba J; Ramalingam TR; Fisher AJ; Wynn TA
Mucosal Immunol; 2016 Jan; 9(1):38-55. PubMed ID: 25921340
[TBL] [Abstract][Full Text] [Related]
18. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
19. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
20. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.
Salimi M; Barlow JL; Saunders SP; Xue L; Gutowska-Owsiak D; Wang X; Huang LC; Johnson D; Scanlon ST; McKenzie AN; Fallon PG; Ogg GS
J Exp Med; 2013 Dec; 210(13):2939-50. PubMed ID: 24323357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
